BioGX

Nov

BioGX Celebrates Success of Global Partnership Initiative, Announces New Distribution Partnerships in EMEA and Asia-Pacific

Amsterdam, The Netherlands, 01 November 2018 – Amsterdam-based BioGX B.V., a subsidiary of Birmingham, Alabama based molecular diagnostics company BioGX, today announced several new...

Oct

BioGX Launches 5 new CE Mark IVD Tests, Expands Number of Sexual Health Panels

Amsterdam, The Netherlands, 23 October 2018 – BioGX B.V. recently released 5 new sexual health CE Mark IVD tests, expanding BioGX’s CE-IVD menu to a total of 21 multiplex panels, with...

May

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

Amsterdam, The Netherlands, 24 May 2018 – BioGX B.V. continues its *BD MAX menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and...

Feb

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

BIRMINGHAM, Ala., Feb. 8, 2018 /PRNewswire/ -- BioGX continues to expand its global presence with the announcement of a distribution partnership between BioGX's Amsterdam-based European...

What's New at BioGX

BioGX Celebrates Success of Global Partnership Initiative, Announces New Distribution Partnerships in EMEA and Asia-Pacific

BioGX Launches 5 new CE Mark IVD Tests, Expands Number of Sexual Health Panels

BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

BioGX and Launch Diagnostics Announce Distribution Partnership For U.K. and Ireland

There is currently no news to display